Stocks | |||||
The table gives an overview of all stocks, alphabetically sorted. | |||||
A B C D E F G H I J K L M N O P Q R S T U V W X Y Z |
Name | Symbol | Analysis date | Close | +/- % |
Marinus Pharmaceuticals | MRNS | Nov 14, 2024 | 0.31 | +2.12 |
Maris-Tech | MTEK | Nov 14, 2024 | 1.81 | -2.69 |
Markel | MKL | Nov 14, 2024 | 1 710.03 | +3.30 |
Marker Therapeutics | MRKR | Nov 14, 2024 | 3.50 | -3.85 |
Market Vectors Bdc Income ETF | BIZD | Nov 14, 2024 | 16.31 | 0.00 |
Market Vectors Investment Grade | FLTR | Nov 14, 2024 | 25.45 | -0.04 |
Market Vectors Israel ETF | ISRA | Nov 14, 2024 | 40.90 | -0.55 |
Market Vectors Preferred Securi | PFXF | Nov 14, 2024 | 17.96 | -0.44 |
MarketAxess | MKTX | Nov 14, 2024 | 264.98 | -0.80 |
MarketWise A | MKTW | Nov 14, 2024 | 0.52 | +3.06 |
Markforged | MKFG | Nov 14, 2024 | 4.29 | -1.83 |
Marpai A | MRAI | Nov 14, 2024 | 1.94 | 0.00 |
Marqeta A | MQ | Nov 14, 2024 | 3.96 | +1.28 |
Marriott International A | MAR | Nov 14, 2024 | 282.02 | -1.55 |
Marriott Vacations Worldwide | VAC | Nov 14, 2024 | 92.83 | +0.14 |
Mars Acquisition | MARX | Nov 14, 2024 | 11.05 | 0.00 |
Mars Acquisition Units | MARXU | Nov 14, 2024 | 11.22 | 0.00 |
Marsh & McLennan Companies | MMC | Nov 14, 2024 | 221.50 | -1.87 |
Marten Tranport | MRTN | Nov 14, 2024 | 17.25 | -2.38 |
Marti Technologies | MRT | Nov 14, 2024 | 1.99 | -0.50 |
Martin Marietta Materials | MLM | Nov 14, 2024 | 587.96 | -2.86 |
Martin Midstream Partners | MMLP | Nov 14, 2024 | 3.99 | +0.50 |
Marvell Technology | MRVL | Nov 14, 2024 | 90.70 | +0.70 |
Masco | MAS | Nov 14, 2024 | 79.19 | -0.08 |
Masimo | MASI | Nov 14, 2024 | 160.15 | -0.95 |
Massimo Group | MAMO | Nov 14, 2024 | 4.16 | -6.94 |
MasTec | MTZ | Nov 14, 2024 | 137.40 | -1.38 |
Mastech Digital | MHH | Nov 14, 2024 | 12.87 | +2.63 |
Masterbrand | MBC | Nov 14, 2024 | 17.01 | +1.13 |
Mastercard | MA | Nov 14, 2024 | 520.40 | -0.28 |
Investtech guarantees neither the entirety nor accuracy of the analyses. Any consequent exposure related to the advice / signals which emerge in the analyses is completely and entirely at the investors own expense and risk. Investtech is not responsible for any loss, either directly or indirectly, which arises as a result of the use of Investtechs analyses. Details of any arising conflicts of interest will always appear in the investment recommendations. Further information about Investtechs analyses can be found here disclaimer.
The content provided by Investtech.com is NOT SEC or FSA regulated and is therefore not intended for US or UK consumers.
Investtech guarantees neither the entirety nor accuracy of the analyses. Any consequent exposure related to the advice / signals which emerge in the analyses is completely and entirely at the investors own expense and risk. Investtech is not responsible for any loss, either directly or indirectly, which arises as a result of the use of Investtechs analyses. Details of any arising conflicts of interest will always appear in the investment recommendations. Further information about Investtechs analyses can be found here disclaimer.
The content provided by Investtech.com is NOT SEC or FSA regulated and is therefore not intended for US or UK consumers.